首页> 美国卫生研究院文献>other >A risk scoring model to predict renal progression associated with postcontrast acute kidney injury in chronic kidney disease patients
【2h】

A risk scoring model to predict renal progression associated with postcontrast acute kidney injury in chronic kidney disease patients

机译:风险评分模型用于预测慢性肾脏病患者对比造影后急性肾损伤的肾脏进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Postcontrast acute kidney injury (AKI) occurs more frequently in patients with lower estimated glomerular filtration rate. We hypothesized that postcontrast AKI in chronic kidney disease (CKD) patients with distinct risk factors might be associated with accelerated renal progression.We undertook this retrospective cohort study to develop and validate a risk scoring model for predicting renal progression. In a development dataset, 18,278 contrast-enhanced CT scans were performed in 9097 patients with CKD (estimated glomerular filtration rate [eGFR] < 60 mL/min/1.73 m2) who were not undergoing dialysis. Postcontrast AKI was observed in 5.8% (1051/18,278) of all contrast-enhanced CTs with 7.6% (689/9097) of the total CKD patients. We investigated the 1-year renal outcome in 224 eligible patients. A risk scoring model was developed with multivariate regression analysis and was assessed in external validation (independent 154 patients).Among 224 patients, 70 (31.3%) patients had progression of renal dysfunction at 1 year (defined as reduction in estimated GFR ≥25% at 1 year). A risk score of 4, 4, 6, 6, 7, or 6 was assigned to diabetes, baseline estimated GFR < 45 mL/min/1.73 m2, hypertension, repeated contrast exposure, congestive heart failure, and persistent renal injury (defined as an elevation of serum creatinine ≥25% at 3 months), respectively. An increasing risk score was associated with renal progression. Of note, persistent renal injury was more prevalent in the progression group than in the non-progression group. The AUROC of the model in the development population was 0.765. In the validation dataset, however, the discriminative power decreased (AUROC = 0.653).Our suggested model provided the risk of renal progression, aiding in predicting prognosis, counseling, and improving outcomes in CKD patients complicated by postcontrast AKI.
机译:估计肾小球滤过率较低的患者发生造影剂后急性肾损伤(AKI)的频率更高。我们假设患有不同危险因素的慢性肾脏病(CKD)患者的对比AKI可能与肾脏进展加快有关。我们进行了这项回顾性队列研究,以开发和验证预测肾脏进展的风险评分模型。在一个开发数据集中,对没有进行透析的9097例CKD(估计肾小球滤过率[eGFR] <60 mL / min / 1.73 m 2 )患者进行了18278例增强CT扫描。在所有对比增强CT中,有5.8%(1051 / 18,278)出现了造影后AKI,而CKD患者中有7.6%(689/9097)。我们调查了224名合格患者的1年肾脏预后。通过多因素回归分析建立了风险评分模型,并在外部验证中进行了评估(独立154例患者)。其中224例患者中,有70例(31.3%)的患者在1年时出现肾功能不全的进展(定义为GFR降低≥25%) 1年)。糖尿病,基线估计GFR <45 mL / min / 1.73 m 2 ,高血压,反复对比暴露,充血性心力衰竭的危险评分分别为4、4、6、6、7或6和持续性肾损伤(定义为3个月时血清肌酐升高≥25%)。风险评分增加与肾脏进展相关。值得注意的是,与非进展组相比,进展组的持续性肾脏损伤更为普遍。该模型在开发人口中的AUROC为0.765。然而,在验证数据集中,判别力下降(AUROC = 0.653)。我们建议的模型提供了肾脏进展的风险,有助于预测并发AKI的CKD患者的预后,咨询和改善结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号